(Q34642726)

3 August 2017

title

Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates (English)

1 reference

3 August 2017

Henri-Jean Aubin

5

0 references

author name string

Mohamed-Ali Gorsane

1

1 reference

3 August 2017

Oussama Kebir

2

1 reference

3 August 2017

Guillaume Hache

3

1 reference

3 August 2017

Lisa Blecha

4

1 reference

3 August 2017

Michel Reynaud

6

1 reference

3 August 2017

Amine Benyamina

7

1 reference

3 August 2017

publication date

1 January 2012

1 reference

3 August 2017

1 reference

3 August 2017

volume

33

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

336-349

1 reference

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Safety and efficacy of baclofen in the treatment of alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Effectiveness and safety of baclofen in the treatment of alcohol dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

The status of disulfiram: a half of a century later

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Disulfiram: an old therapeutic with new applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Does disulfiram have a role in alcoholism treatment today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Naltrexone in the treatment of alcoholism: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Predicting treatment response to naltrexone: the influence of craving and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Emerging drugs to treat alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Addiction as a computational process gone awry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Drug therapy for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Two types of neurone in the rat ventral tegmental area and their synaptic inputs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Role of the GABA(B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

The action of gamma-aminobutyric acid on cortical neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Is gamma-aminobutyric acid an inhibitory transmitter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

The 'ABC' of GABA receptors: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

GABA(B)-receptor subtypes assemble into functional heteromeric complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Immunocytochemical localization of GABABR1 receptor subunits in the basolateral amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Differential involvement of ventral tegmental GABA(A) and GABA(B) receptors in the regulation of the nucleus accumbens dopamine response to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA(B) receptors is altered after repeated amphetamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen for binge eating: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Positive effect of baclofen on body weight reduction in obese subjects: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Ethanol enhances GABAergic transmission onto dopamine neurons in the ventral tegmental area of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Role of the GABA(B) receptor in alcohol-seeking and drinking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen reduces ethanol intake in high-alcohol-drinking University of Chile bibulous rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen suppresses motivation to consume alcohol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Ethanol-induced sensitization depends preferentially on D1 rather than D2 dopamine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Differential effects of GABA(A) and GABA(B) agonists on sensitization to the locomotor stimulant effects of ethanol in DBA/2 J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Naloxone and baclofen attenuate ethanol's locomotor-activating effects in preweanling Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Ventral tegmental area region governs GABA(B) receptor modulation of ethanol-stimulated activity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen alters ethanol-stimulated activity but not conditioned place preference or taste aversion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Suppression of ethanol-induced locomotor stimulation by GABA-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

The amygdala regulates the antianxiety sensitization effect of flumazenil during repeated chronic ethanol or repeated stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55,212-2 in alcohol-preferring rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Craving's place in addiction theory: contributions of the major models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen as a cocaine anti-craving medication: a preliminary clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen for alcohol dependence: a preliminary open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Psychometric properties of the Penn Alcohol Craving Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Insulin but not insulin growth factor-1 correlates with craving in currently drinking alcohol-dependent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

[A system of prescriptions without drug approval: example of baclofen].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Suppression of symptoms of alcohol dependence and craving using high-dose baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

A SELF-RATING DEPRESSION SCALE

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

21 January 2018

Baclofen for alcoholism

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Rapid suppression of alcohol withdrawal syndrome by baclofen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Suppression of alcohol delirium tremens by baclofen administration: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Behavioral disinhibition with baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

Acute interaction of baclofen in combination with alcohol in heavy social drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08897077.2012.663326

10.1080/08897077.2012.663326

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference